Adcock Ingram misses out on main ARV tender despite state’s localisation goal
SA pharmaceutical manufacturer overlooked as department of health awards half of R11bn antiretroviral tender to companies in India
19 July 2022 - 23:35
A local pharmaceutical industry body is questioning why almost half of the main medicines in a three-year R11bn antiretroviral (ARV) tender will be bought from Indian companies while SA’s Adcock Ingram was overlooked.
The tender is awarded by the department of health every three years and covers all the ARV drugs used by the state in the world’s largest HIV treatment programme...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.